Retatrutide mimics the effects of naturally occurring gut hormones to improve metabolic health. Stimulating insulin release ...
Artificial Intelligence (AI) is poised to revolutionise healthcare, from streamlining administrative tasks to detecting ...
Who doesn’t love the comforting warmth of a cocoa drink on a chilly evening? Beyond its rich, velvety flavour and nostalgic ...
However, cardiovascular diseases remain the primary cause of death in MAFLD patients, and individuals with MAFLD are at ...
Emergen Research Logo The increasing prevalence of liver diseases worldwide is a major growth driver in the liver disease therapeutics mark ...
Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), a leading API and formulation manufacturer, announces that the Subject Expert Committee (SEC) of CDSCO has approved its Investigational New Drug ...
Discover how circulating cell-free DNA (cfDNA) is transforming the diagnosis and monitoring of metabolic diseases like ...
Due to today's hectic life and unhealthy lifestyle, Fatty Liver is becoming a common problem. Especially Non-Alcoholic Fatty ...
Metabolic dysfunction-associated fatty liver disease (MAFLD) has become a growing global health concern, affecting millions ...
Liver fibrosis is a major global health concern, developing as a result of chronic liver diseases (CLDs) such as viral ...
SLIM LIVER was the first clinical trial to test semaglutide as a treatment for MASLD in people living with HIV. MASLD, previously known as non-alcoholic fatty liver disease (NAFLD), is a common and ...
Metabolic dysfunction-associated fatty liver disease (MAFLD) has become a growing global health concern, affecting millions ...